Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Platt

Showing results (141-150 of 272) with videos related to

Pageof 28
Sort By:
Clinical Pharmacology and Therapeutics|October 21, 2019
Reproducing Protocol-Based Studies Using Parameterizable Tools-Comparison of Analytic Approaches Used by Two Medical Product Surveillance NetworksTing-Ying Huang, Emily C Welch, Mayura U Shinde, et al.
Clinical Pharmacology and Therapeutics|April 7, 2021
When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?Jessica M Franklin, Richard Platt, Nancy A Dreyer, et al.
Therapeutic Advances in Drug Safety|November 26, 2020
Prescribing cascades in persons with Alzheimer's disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materialsSarah Bloomstone, Kathryn Anzuoni, Noelle Cocoros, et al.
Archives of Internal Medicine|May 10, 2006
Reducing warfarin medication interactions: an interrupted time series evaluationAdrianne C Feldstein, David H Smith, Nancy Perrin, et al.
Pharmacoepidemiology and Drug Safety|January 25, 2008
Adverse events associated with prolonged antibiotic useSharon B Meropol, K Arnold Chan, Zhen Chen, et al.
Infection Control and Hospital Epidemiology|January 21, 2014
Impact of Medicare's payment policy on mediastinitis following coronary artery bypass graft surgery in US hospitalsMichael S Calderwood, Ken Kleinman, Stephen B Soumerai, et al.
Pharmacoepidemiology and Drug Safety|August 8, 2006
Risk factors for statin-associated rhabdomyolysisStephanie Schech, David Graham, Judy Staffa, et al.
Infection Control and Hospital Epidemiology|January 10, 2012
Beyond 30 days: does limiting the duration of surgical site infection follow-up limit detection?Julie D Lankiewicz, Deborah S Yokoe, Margaret A Olsen, et al.
Archives of Internal Medicine|March 12, 2008
A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarctionDavid H Smith, Judith M Kramer, Nancy Perrin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Advanced Clinical Decision Support for Vaccine Adverse Event Detection and ReportingMeghan A Baker, David C Kaelber, David S Bar-Shain, et al.
Pageof 28

Showing results (141-150 of 272) with videos related to

Sort By:
Pageof 28
Clinical Pharmacology and Therapeutics|October 21, 2019
Reproducing Protocol-Based Studies Using Parameterizable Tools-Comparison of Analytic Approaches Used by Two Medical Product Surveillance NetworksTing-Ying Huang, Emily C Welch, Mayura U Shinde, et al.
Clinical Pharmacology and Therapeutics|April 7, 2021
When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?Jessica M Franklin, Richard Platt, Nancy A Dreyer, et al.
Therapeutic Advances in Drug Safety|November 26, 2020
Prescribing cascades in persons with Alzheimer's disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materialsSarah Bloomstone, Kathryn Anzuoni, Noelle Cocoros, et al.
Archives of Internal Medicine|May 10, 2006
Reducing warfarin medication interactions: an interrupted time series evaluationAdrianne C Feldstein, David H Smith, Nancy Perrin, et al.
Pharmacoepidemiology and Drug Safety|January 25, 2008
Adverse events associated with prolonged antibiotic useSharon B Meropol, K Arnold Chan, Zhen Chen, et al.
Infection Control and Hospital Epidemiology|January 21, 2014
Impact of Medicare's payment policy on mediastinitis following coronary artery bypass graft surgery in US hospitalsMichael S Calderwood, Ken Kleinman, Stephen B Soumerai, et al.
Pharmacoepidemiology and Drug Safety|August 8, 2006
Risk factors for statin-associated rhabdomyolysisStephanie Schech, David Graham, Judy Staffa, et al.
Infection Control and Hospital Epidemiology|January 10, 2012
Beyond 30 days: does limiting the duration of surgical site infection follow-up limit detection?Julie D Lankiewicz, Deborah S Yokoe, Margaret A Olsen, et al.
Archives of Internal Medicine|March 12, 2008
A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarctionDavid H Smith, Judith M Kramer, Nancy Perrin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2015
Advanced Clinical Decision Support for Vaccine Adverse Event Detection and ReportingMeghan A Baker, David C Kaelber, David S Bar-Shain, et al.
Pageof 28